PolyMedix (PYMX.OB) Initiates Phase II Clinical Trials of Anticoagulant to Address Unmet Medical Needs
PolyMedix Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders,…